The growth impetuses in the hospital-acquired infection diagnostics market are expanding at a noticeable speed because of numerous factors. Amongst these major factors, is the rising prevalence in the cases of hospital-acquired infections.
Advances in biotechnology have expanded its industrial and commercial applications beyond agriculture and medical markets. An array of technical factors have been drivers and/or accelerators of the strides in the biotechnology market. Recombinant DNA (rDNA) technology has increased the scope of synthetic biology, and has been one of key technical drivers of the industry over the past five decades. In recent years, the cost of DNA sequencing has decreased considerably, paving way to commercialization of a slew of biotechnology products. Industry players have been leveraging modern tools of genome editing, such as CRISPR-Cas9, along with advances in bioinformatics to scale analysis and design of these products.
Understanding the role of how RNA interference (RNAi) modulated gene expression has helped scientists unveil new synthetic biology tools for agriculture. Standardization in synthetic biological parts and rapid design-build-test-learn cycles are at the forefront of technical factors accelerating the advances in the biotechnology market. More promising biotech products will also hit the market in coming years from advances in public and private biofoundries. Apart from technical drivers for the biotechnology market, social and economic drivers have also gained significance from growing interest of the private players and participation of governments, particularly of developed markets such as in North America and Europe. The growing complexity of genome editing for deciding biotechnology regulatory system is a case in point.
Evolving regulatory frameworks for biotechnology markets in various markets must focus on the societal concerns, in addition to technical risks. Further, trends in regulations and government oversight will set new paradigms for research and product development, such as by diversifying sources of capital. These frameworks will also play crucial role in shaping the intensity of competition and deciding entry barrier level for new entrants.
Our intelligence reports on various biotechnology markets shed light on various technical, societal, and economic drivers, including the role of governments. A number on reports shed light on non-traditional actors that set the pace for new niches in specific biotechnology markets. New avenues for next-generation biotechnology products are also analyzed in a few reports.
The growth impetuses in the hospital-acquired infection diagnostics market are expanding at a noticeable speed because of numerous factors. Amongst these major factors, is the rising prevalence in the cases of hospital-acquired infections.
The growth in the protein crystallization market has been growing rapidly because of a lot of factors. One of the prominent growth factors includes the rising adoption of protein therapeutics. Along with this, the growing concentration on miniaturization and technological advancements in protein crystallization consumables and instruments are also predicted to drive growth impetuses in the global market during the forecast period.
The growth in the metagenomic sequencing market has been owing to numerous factors. The market growth is generally attributed to the constant technological innovations in the NGS platforms. Along with this, growing funding and initiatives from the private & government bodies for the large-scale sequencing projects are also bolstering expansion avenues in the global market in the coming years.
The size of the preimplantation genetics diagnosis (PGD) market has been estimated to grow at a significant speed in the forthcoming years. This rapid growth in the market is on the basis of the high accuracy of the PGD in order to detect genetic disorders. In addition to this, increasing investment to detect genetic disorders along with chromosomal abnormalities around the world is also expected to propel growth opportunities in the global market in the near future.
The mesenchymal stem cells market has been projected to expand significantly in the upcoming years. These rapid growth opportunities in the market are due to increasing R & D activities that are based on mesenchymal stem cells. These cells are further used at an increasing rate in the area of regenerative medicine. So, based on these factors, the global market is likely to experience new demand opportunities in the following years.
The photomedicine market has been estimated to grow at a noteworthy speed during the forecast period. These growth prospects in the market are owing to the rising number of people that are suffering from vision problems. These vision issues are occurring because of natural causes, for instance, excessive use of computers or television or due to injury to the head that leads to ophthalmological issues.
The refurbished DNA sequencing platforms market has been estimated to grow at a noteworthy speed throughout the forecast period. The growth avenues in the global market have been attributed to the increasing applications and usage of DNA sequencing, majorly in reproductive health, diagnostics, oncology research, and others.
The cell culture media market has been projected to expand at a noteworthy pace throughout the forecast period. The growth avenues in the global market are attributed to the availability of several nutrients in culture media that further aid in the storage, maintenance, proliferation, and growth of microbial and some other cell types, for instance, stem cells and others.
The multiplex assay market has been anticipated to experience novel growth prospects throughout the forecast period. The growth avenues in the global market are attributed to various factors, such as the rising adoption of companion diagnostics, rising awareness about disease diagnosis, and growing incidence of infectious and chronic diseases.
The blood gas and electrolyte analyzers market has been anticipated to expand at a rapid pace throughout the forecast period. The growth impetuses in the global market are attributed to the rising prevalence of different chronic diseases.
The renal biomarkers market has been estimated to grow at a noticeable speed in the following years. The growth prospects in the global market are commonly attributed to numerous factors, such as the increasing prevalence of numerous kidney-related diseases.
The magnetic beads market has been estimated to grow at a noticeable speed in the upcoming years. The growth avenues in the global market are attributed to numerous factors, for instance, increasing demand for products in different types of genetic and biological research processes.
The biobanking market has been estimated to experience novel growth opportunities in the forthcoming years. The growth avenues in the global market are attributed to numerous factors, for instance, the rising number of biobanks around the world.
The protein expression market has been projected to grow at a noticeable speed in the following years. The growth avenues in the global market are attributed to the well-established industry because of the acceptance of these services across the world. Along with this, the expression is performed without using any living cells.
The sperm bank market has been anticipated to experience various novel growth opportunities in the near future. The growth avenues in the global market are attributed to the increasing acceptance of the LGBTQ+ community. The sperm banks allow the community to undergo the in-vitro process and then have a baby.
The RNA based therapeutic market has been projected to grow at a rapid pace in the foreseeable years. These growth prospects in the global market are attributed to the increased attention to these RNA based therapeutics because of their potential in order to treat various chronic diseases, for instance, tuberculosis, AIDS, diabetes, and cancer.
The DNA vaccine market has been estimated to experience numerous novel growth opportunities in the foreseeable years. These growth avenues in the global market are commonly attributed to the increasing number of cases of cancer around the world. In addition to this, the rising count of infectious diseases among human beings and animals is also predicted to fuel the expansion avenues in the global market in the near future.
The U.K. cell and gene therapy research challenges market has been anticipated to grow at a rapid pace in the foreseeable years. These growth avenues in the global market are predicted to grow with the increasing number of R & D activities in order to develop novel technologies in the industry.
The isothermal nucleic acid amplification technology/INAAT market has been estimated to experience numerous growth opportunities in the following years. These growth impetuses in the global market are majorly driven by numerous factors, for instance, the introduction of novel pathogens and the rising prevalence of infectious diseases.
The bioprocess containers market has been estimated to expand at a significant speed in the foreseeable years. These growth opportunities in the global market are commonly attributed to the growing biologics market. In addition to this, rising biopharmaceutical R & D activities and sustainability and affordability of the single-use bioprocess technologies are also bolstering expansion avenues in the global market in the following years.
The animal growth promoters and performance enhancer market has been anticipated to grow at a noteworthy speed in the years to come. The growth opportunities in the global market are attributed to the increasing application of the animal health products, such as promoters and performance enhancers for the growth of different animals
The genomic biomarker market has been projected to grow at a noticeable speed in the forthcoming years. The growth in the global market has been attributed to the growing burden of chronic diseases, for example, arthritis, cancer, heart attack, stroke, and others. These increasing cases are on the back of various factors, such as reduced physical activities, smoking, and unhealthy lifestyle that are likely to propel demand opportunities in the global market as the clinical diagnostic tool.
The protein therapeutics market has been anticipated to experience various growth opportunities in the years to come. The growth in the market has been on the back of the rising demand for MAbs across the world. In addition to this, the sudden outbreak of the COVID-19 around the world has also put a neutral impact on the market growth during and after the post-pandemic situation.
The microarray analysis market has been expected to grow at a substantial speed in the years to come. The growth in the global market has been possible with the rising application of personalized medicine across the world. The use of these personalized medicines serves as a noteworthy factor to drive the growth impetus in the global market during the forecast period.
The gene synthesis market has been estimated to experience various growth opportunities in the forthcoming years. The rapid growth in the global market has been possible with the supportive government policies that are associated with synthetic biology. In addition to this, the rising requirement for synthetic biology has made a shift in the investors concentration to this field.
The T-cell lymphoma market has been estimated to experience noticeable growth opportunities in the following years. The market growth has been possible with the rising incidence of lymphoma cancer because of radiation. Along with this, the growing risk of lymphoma on the back of autoimmune disorders is also predicted to contribute to the growth impetus in the market.
The small scale bioreactors market is estimated to experience innumerable growth opportunities in the following years. The growth in the global market has been possible with the growing use of single use bioreactors. The sudden outbreak of the COVID-19 cases has been estimated to fuel demand opportunities in the market.
The virology specimen collection market has been anticipated to grow at a noticeable pace in the years to come. The growth in the market can be attributed to the rising count of blood donations and the growing prevalence of cervical cancer and human papillomavirus. Along with these factors, the increasing prevalence of viral diseases among people across the world is also serving as the growth driving factor in the market.
The western blotting market has been anticipated to grow at a noteworthy speed in the years to come. Market growth is possible with the rising rate of technological advancements, growing prevalence of HIV cases, and increasing demand for personalized medicine. Along with these factors, there has been a noticeable increase in government funding to conduct R & D activities in the biomedical industry.
The tissue microarray market has been anticipated to grow at a significant speed in the years to come. Market growth has been possible with the rising use of microarrays in different applications, for example, biomarker identification, toxicological response profiling, pharmaceutical target screening, and molecular biology. Thus, based on the wide array of applications, the tissue microarray market has been projected to grow at a noticeable speed in the years to come.
The automated and closed cell therapy processing systems market is predicted to grow at a noteworthy speed in the upcoming years. The market growth is on the back of the increasing popularity of regenerative medicines and cell therapies. In addition to this, various benefits that are provided by the automation technologies for the comprehensive development of therapies are also adding to the market growth.
The laboratory filtration market has been estimated to grow at a significant speed during the forecast period. This market growth has been on the back of increased spending on R & D activities in the pharmaceutical and biopharmaceutical industry. In addition to this, rising concentration to develop large-molecule biopharmaceuticals, growing purity requirements in the end-user segments, and increasing demand for the membrane filtration technology is also contributing to the expansion avenues in the market in the years to come.
The chemiluminescence immunoassay market has been estimated to grow at a significant speed during the forecast period. This market growth has been attributed to the emerging cases of HIV (human immunodeficiency virus disease). Not only limited to specific regions around the globe, but the majority of the nations at the global level are experiencing increased cases of HIV every year. In addition to this, the mortality rate due to this disease is comparatively higher. Thus, owing to these factors, the market has been predicted to experience significant growth impetus in the forthcoming years.
The aptamers market has been estimated to experience noteworthy growth opportunities during the forecast period. This rapidly increasing market growth has been attributed to the increasing number of clinical trials, growing cases of chronic and other rare diseases, and rising investment in the R & D activities in pharmaceutical companies. In addition to this, increasing awareness related to the advantages of the aptamers compared to the antibodies are also boosting growth impetus in the market in the years to come.
The molecular biology enzymes, kits, and reagents market has been predicted to grow at a significant speed in the incoming years. The increasing market growth is primarily attributed to the increasing count of genome disorders and an increasing number of different R & D activities. The companies have also been increasing their investments in these R & D activities.
The genome engineering market has been anticipated to experience noteworthy growth opportunities in the forthcoming years. The increasing market growth has been primarily driven by different factors such as the growing number of genomics projects. In addition to this, the easy availability of government funding is also likely to fuel growth prospects in the global market in the upcoming years.
The ataxia market has been anticipated to experience noteworthy growth prospects in the forthcoming years. This increasing market growth is on the back of rising cases of ataxia and a constantly improving rate of diagnosis. In addition to this, various technological advancements in pharmacotherapy in order to provide treatment against the symptoms of ataxia are also fueling growth prospects in the market.
The Latin America insulin vials market has been anticipated to experience significant growth avenues in the forthcoming years. This increasing market growth is on the back of a growing count of people adopting quality healthcare, increasing demand for advanced technologies in diabetes therapy, and rising concentration of the manufacturers on the emerging markets.
The bovine serum albumin market has been estimated to experience significant growth opportunities in the forthcoming years. This increasing market growth is on the back of a novel product launch in the field of bovine serum albumin. Further, the rising use of this serum as a dietary whey protein is also boosting growth opportunities in the market.
The C-reactive protein testing market is projected to experience significant growth opportunities in the forthcoming years. Plasmonic Nanoparticles (PNPs) have been among the significant tools that are applied for biosensing applications because of their versatile optical properties.
The biotechnology instruments market is projected to experience growth opportunities in the upcoming years. This market growth is on the back of the increasing adoption of point-of-care diagnostic devices. The point-of-care testing system is undergoing various technological advancements due to the increasing rate of R & D activities.
Increasing demand from varied set of fields such as medical diagnosis, drug expansion and detection, as well as ecological and agricultural research is supplementing the growth in global protein characterization and identification market in near future.
A coronavirus is a group of encompassed, single abandoned RNA infections that taint people, chimpanzees, different warm-blooded creatures, and avian species. Coronavirus for the most part causes gastrointestinal and respiratory contaminations. It takes around two to fourteen days for an individual to show manifestations after openness to the infection.
The growing biopharmaceutical research and development activities, technological advancements in SUB, and growing biologics market are some of the key factors responsible for the growth in the single-use bioreactor market. In addition, reduced water and energy consumption, ease to cultivate marine organisms, and reduced automation complexity are also bolstering demand in the single-use bioreactor industry.
The single use bioprocessing market is driven by an increased requirement for the reduction of water wastage and a growing need for biopharmaceuticals and energy efficiency. In addition, the threat of cross-contamination and equipment floor space needs are also bolstering demand in the single use bioprocessing industry.
The cell & gene therapy manufacturing services market is majorly driven by rising agreements and partnerships between CDMOs and pharmaceutical companies. Other factors responsible for the growth in the cell & gene therapy manufacturing services industry include the increasing rate of investment in advanced technologies and pharmaceutical research and development activities.
The increasing count of neurological disorders serves as a prominent driver for the growth in the neurological biomarkers market. WHO has published an estimation in 2018 that more than 300 million people from different age groups encounter clinical depression across the world. It is anticipated to fuel demand in the industry.
The histology and cytology market is growing with advancements in virtual microscopy patterns. Liquid-based cytology is also adopted at an increasing rate that boosts growth in the industry. The extensive usage of digital pathology, along with other applications is bolstering growth in the histology and cytology market.
There is a rapid increase in chronic diseases that are closely associated with human genes. Such diseases in the line include arthritis, cancer, heart attack, stroke, and some other relative illnesses. This wide range of diseases is expecting to fuel growth in the global gene panel market in the upcoming years.
The solution from the cardiac biomarkers market prevents cardiac disease by effective monitoring of heart conditions. For this monitoring, cardiac biomarker testing tools serve as a profound approach to obtain rapid outcomes for immediate diagnosis and treatment.
The increasing importance of sustainable crop production is a prime factor augmenting the growth of the global plant phenotyping market. Plant Phenotyping is a quantitative explanation of a plant's physiological, biochemical, ontogenetical, and physical properties.
The rising adoption of a sedentary lifestyle and the increasing prevalence of various chronic diseases are prime factors augmenting the growth of the blood and blood components market. Blood implies the fluid that streams in the vascular game plan of most animals, including individuals. Its four essential components are the red blood cells, white blood cells, platelets, and plasma.
The large molecule bioanalytical testing services market will observe a positive growth trajectory across the forecast period of 2020-2030. The growing demand for quality and technologically advanced large molecule bioanalytical testing services will serve as a profitable growth-generating factor. Innovation in the healthcare sector is also expanding at a rapid rate, thus, increasing the growth prospects of the global market.
Vitrification has developed with the growing number of fertility preservation techniques. These techniques are efficient to preserve specimens that reduce preservation time as well as minimize cryoprotectants exposure. It has spurred growth in the vitrification market and also added lucrative opportunities for revenue generation.
The onset of gene therapy and development in tissue engineering, as well as stem cells, are boosting the regenerative medicine market. The rising regulatory approvals for the growth of advanced therapy medicinal products will propel growth in the market. There has been an urgent requirement to develop new therapies for the treatment against SARS-COV-2 to cure patients. Different initiatives are also taken for the manufacturing of cell and gene therapy.
Point-of-care testing for glucose monitoring is a valuable tool for managing patients with diabetes in the outpatient settings. Coupling of POCT glucose monitoring devices and electronic medical records enable test results to be shared instantly with care providers.
The concept of laboratory automation is gaining decent traction as the organizations engaged in this field are growing interest toward capitalizing and optimizing diverse technologies in their laboratories. The notion of laboratory automation system covers various aspects of laboratories including automated lab instruments, software, and devices that provide advantages including advanced productivity, cycle time reduction, data quality improvement, and workflow coverage enhancement.
The laboratory supplies market is estimated to gain tremendous growth prospects across the assessment period of 2020-2030. The growing demand for laboratory products on the back of the advancements in the chemical and biological research field will bring immense opportunities for the global market during the forecast period.
The rising cases of infectious diseases and various types of chronic diseases such as cancer are projected to add boost to the overall rapid microbiology testing market. Rapid microbiological methods are the latest form of microbiology used for detecting the risk of a microbial infection or track crucial control points in real-time. This method is widely used for the production of drugs, for medicine, and various biotechnological aspects.
Growth in the collagen and gelatin market is driven by factors such as the rising prevalence of target diseases and disorders, rising number of surgeries coupled with growing geriatric population, and investments in R&D. However, the availability of efficient and reliable substitute biomaterials is expected to restrain the market growth during the forecast period.
The growing desire for continual manufacturing, the booming biopharmaceutical sector, and growing usage of single-use technologies are all likely to add to the development of the global hollow fiber filtration market in the years to come.
The rising prevalence of oncology indications for cancer therapeutics is projected to augment the growth of the U.S. cancer biopsy market during the forecast period, 2020 to 2030. Biopsies are ordinarily connected with cancer, yet in light of the fact that your PCP arranges a biopsy, it doesn't imply that you have cancer. Specialists use biopsies to test whether irregularities in your body are brought about by cancer or by different conditions.
The increasing cases of various cancer types have created numerous research and development activities. One of these includes the study of micro RNA sequencing and assay by synthesis, the increasing number of ongoing research of which is prognosticated to boost the global miRNA sequencing and assay market. miRNA sequencing is the utilization of massively parallel high-throughput DNA sequencing or next-generation sequencing for sequencing microRNAs.
The growing demand from biomarkers and the rising applications of transcriptomics technologies across the globe will prove to be a boon for the growth of the spatial OMICS market during the assessment period of 2020-2030. The expanding prevalence of cancer and other chronic diseases will also prove to be a major growth contributor for the spatial OMICS market.
The growing prevalence of cancer and the expanding geriatric population will serve as prominent growth generators for the biopsy guidance system market during the assessment period of 2020-2030. The cancer prevalence rate around the world is increasing at a rapid pace. The swelling fatality rate of cancer and the escalating need to control it will invite exponential growth for the biopsy guidance system market during the tenure of 2020-2030.
Lung cancer screening is an interaction that is utilized to recognize the presence of lung cancer in a healthy person with a high danger of lung cancer. Lung cancer screening is suggested for old adults who are accustomed to long-term smoking habits and don't convey any signs of lung cancer. The increasing population of smokers worldwide is a prime factor augmenting the growth of the global market for lung cancer diagnostic and screening during the forecast period set between 2020 and 2030.
Amniotic membrane is the deepest layer of fetal membrane which is extricated from placenta of ladies and reaped to be utilized as a transfer material for reconstructive medical procedure for cases like seriously consumed skin, injury wounds, ongoing injuries and others. The use of amniotic membrane market in a number of surgeries is projected to boost the growth of this market during the forecast period, 2020 to 2030.
Human tissue is excised for either medical care or research. Demand for excised human tissue is increasing because of the realization of personalized medicine, which relies on excised human tissue to develop innovative tests for application in patient care. However, because excised human tissue is a limited, nonrenewable resource, increasing demand has stressed current institutional infrastructures.
Cellular health screening is a progressive innovation that is utilized for fast analysis of health at a cellular level. The test is demonstrating the functionalities of the cells towards the body. Additionally, the test is helpful to screen the advancement of gave treatment. The screening is help to decide the conditions including cellular harmfulness, fat mass, dynamic tissue mass, intra, and extracellular liquid levels, and cellular health and capacities.
The COVID-19 saliva screening test potential market will observe revolutionary growth across the assessment period of 2020-2030. The heightening demand for rapid testing methods among a considerable chunk of the global populace will help in inviting promising growth for the COVID-19 saliva screening test potential market through the tenure of 2020-2030.
Stem cells refer to special cells created by bone marrow of an individual. The key specialty of these cells is their ability to turn into various types of blood cells. Stem cells are gaining immense impetus owing to their key role in effectual disease management and specialized research activities including genomic testing and personalized medicine.
The worldwide pharmaceutical industry is experiencing notable growth in research and development activities. This factor is expected to work as a key driver for the growth of the global cell dissociation market during the assessment period 2020–2030. The market for cell dissociation is expected to gather lucrative avenues in various emerging economies such as India, Brazil, and China. One of the important factors supporting this growth of cell dissociation market is increase in research activities in the life sciences sectors of these regions.
Demands for antibodies have risen strikingly for a range of research and diagnostic applications. Particularly, the demand for custom antibodies for drug development and diagnostics has grown steadily over the past few decades. Various sources have come to the fore, but a significant percentage have been found to fail validation process, raising concern to producers as well as medical researchers.
Scaffold materials and the tissue engineering technologies have been the result of culmination of advances in materials sciences and burgeoning arena of regenerative medicine. Scaffolding technology has shown a profound potential in tissue regeneration, with the materials have been utilized in stem cell-based engineered tissue replacements. Tissue engineered have received a groundswell of attention among pioneers of regenerative medicine. Medical researchers are relentlessly looking for ways to use biocompatible scaffold materials to restore and replace tissues and damaged organs.
The viral vector and plasmid DNA s are being increasingly used in clinical trials as they provide the highest accuracy in delivering the gene to the region of interest. Adenoviral vector and plasmid DNA s are considered safe and are being extensively used as vaccines due to their capability to induce strong humoral and T cell responses. The potential to elicit a wide immune response, safety profiles, and easy manufacturing are enabling a high implementation of viral vector and plasmid DNA s in vaccine development.
The increasing number of government funding and investments used for intense research and development activities for medical diagnostics is expected to boost the growth of the global single-cell analysis market during the forecast period 2020 to 2030. Single-cell analysis is the study of proteomics, metabolomics, proteomics, genomics, and transcriptomics, along with cell interactions at the single cell level. It is used to determine the heterogeneity among people, and identify minority amongst group of people. It can also be used to discover unique characteristics in individual cells as well.
The rise in research and development activities on large molecules and chemical compound is a prime factor projected to aid in expansion of the global large molecule Bioanalytical technologies market during the forecast period, 2020 to 2030. Bioanalysis is a sub-control of scientific science covering the quantitative estimation of xenobiotics (drugs and their metabolites, and organic molecules in unnatural areas or focuses) and biotics (macromolecules, proteins, DNA, large molecule drugs, metabolites) in natural frameworks.
The escalating use of genetic tests, decreasing sequencing costs, promising funding initiatives from various firms and conglomerates coupled with the enhancements in regulatory reforms are some of the factors that will bring extensive growth for the consumer genomics market during the forecast period of 2020-2030.
The growing prevalence of chronic diseases, infections, and disorders are urging many individuals to get tested for any ailments or health problems at an earlier stage. A large number of tests are available for detecting varied diseases and disorders in the body. Blood tests are one of the most effective and common types of testing methods used for infection or disease detection. The growing awareness among the global populace about the importance of blood testing will bode well for the growth of the global blood testing market across the assessment period of 2020-2030.
Cell and gene therapies’ rapid penetration in clinical trials globally is testimony to the incredible potential these in understanding, treating, and curing diseases. The cell and gene therapy clinical trials market is rapidly evolving, touching numerous frontiers in personalized medicine, especially for chronic diseases. A number of gene therapies approved by the U.S. FDA reinforces the potential.
Oxidative stress leads to range of cellular disorders caused by the excess of reactive oxygen species (ROS). It is caused by the presence of excess free radicals, leading to cellular damage at various levels. Some of the common molecules characterizing ROS are peroxides, hydroxyl radicals, singlet oxygen, alpha-oxygen, and superoxide. Some of the indirect metrics of the measure of symptoms are DNA/RNA damage, protein oxidation/nitration, and lipid peroxidation. Some of the key diseases are ischemia, atherosclerosis, rheumatoid arthritis, neurodegeneration, and cancer.
The primary cell culture market is estimated to observe promising growth on the back of the rising cases of autoimmune diseases, cancer, cardiovascular diseases, chronic conditions, diabetes, nephrological diseases, and others across the assessment period of 2020-2030. The growing utilization of primary cell culture in various applications, especially in the biotechnology and pharmaceutical sector will bring tremendous growth opportunities for the primary cell culture market.
The increasing demand for custom-made nucleotides for the required sequence through analysis, forensic applications, drug production, and genetic testing has resulted from the decreasing cost of sequencing. As a result, the global oligonucleotide synthesis market has grown through a variety of life science industries.
The infectious disease in-vitro diagnostics market is prognosticated to observe promising growth across the assessment period of 2020-2030 on the back of the rising prevalence of infectious diseases around the world. The increasing incidences of infectious diseases and the growing need to tackle them at an early stage have led to tremendous advancements in terms of diagnostics.
Polymerase Chain Reaction (PCR) is a tool used in medical and biological research labs to make millions of copies from small amount of DNA. PCR is used for detecting the pathogens in the body during infection whether they are present or not. As PCR device can be utilised to detect various diseases such as AIDS, Lyme diseases, tuberculosis, etc. Its advantage of giving results in less time is another factor why its demand can be lucrative in the near future.
The increasing cases of infectious diseases are a prime factor augmenting the growth of the global digital PCR and real-time PCR market during the forecast period set between 2020 and2030. The increasing geriatric population, coupled with the rising number of genetic disorders is also propelling growth of this market. Furthermore, the persistent mechanical headways in PCR advances, the fruitful fulfillment of the human genome project, and expanding R&D speculations, assets, and awards just as the expanding utilization of biomarker profiling for sickness diagnostics.
A number of methods in cell lysis market are used for cell lysis or cell fractionation, which mainly consist of disintegration of cell membranes partially or fully to obtain inter-cellular materials. Protein, RNA, or DNA are some of the most common materials that are released as a result of cell lysis. The process is thus useful for industry players for making various bimolecular analyses such as in the study of specific proteins, lipids, and nucleic acids.
The transition from stainless-steel bioreactors to single-use bioreactors, as well as increased investment on research and development activities by biotechnology and pharmaceutical companies, are likely to drive growth of the global microcarrier market in the years to come. Rising demand for cell-based therapeutics and vaccines, the accelerated growth of the biologics and biosimilar sector, and increased research and development activities and financing for cell therapy research are all likely to benefit the global microcarrier market.
Increasing occurrence of lifestyle conditions and chronic disease, technical innovations in cell-based methodologies, and augmented investments in research and development activities for drug-discovery is likely to support rapid expansion of the global cell-based assays market. One of the driving forces of the market is likely to be the high prevalence of chronic conditions such as neurological problems, cardiovascular, diabetes, and cancer.
The growing influence of technology across the life science research, molecular diagnostics, and forensics will boost the growth of the nucleic acid isolation and purification market through the assessment period of 2020-2030. The rising demand for research and development activities from life sciences sector will bring tremendous growth opportunities.
The global microRNA market is predicted to expand at a whopping growth rate over the 2020 – 2030 forecast period. This is mainly attributed to emergence of microRNA tools for disease-related analytical applications, immense traction earned by miRNA targeted prediction and identification, continued wide adoption of majority of miRNA tools.
Increasing focus of pharmaceutical companies on the development of advanced monoclonal antibodies is projected to help augment the growth of the global monoclonal antibodies market during the forecast period, set between 2020 and 2030. Monoclonal antibody therapy is gaining popularity by the day on account of the rising prevalence of chronic diseases such as cancer worldwide.
Genomics refers to the study of structure, function and inheritance of the genome of an organism. Genomic technology offer opportunities to improve healthcare across the breadth of medical specialities.
The rise in target patient population is considered a key factor boosting the global gene expression market and likely to continue doing so in the forecast period set between 2020 and 2030. The diminishing expense of sequencing strategies and the accessibility of gene expression data sets are relied upon to fuel the development of the market in the coming years
Rising incidences of chronic diseases, innovative recombinant products, augmented spending on research and development activities, and a growing preference for biosimilars and biologics are all contributing toward the expansion of the global recombinant protein market. Novel therapies for the purpose of treatment of serious chronic diseases such as cancer and other rare diseases are being developed utilizing recombinant proteins.
The expansion of the global biopharmaceutical third party logistics market is estimated to be driven by growing trend of outsourcing logistics. In addition, increase in the number of biosimilar launches and emphasis of pharmaceutical companies on their distribution network due to high sales is likely to augur well for the market.
Development of assays that feature as rapid medical diagnostics attracts groundswell of interest of healthcare systems worldwide. The copious interest stems from the growing prevalence and burden of chronic and infectious diseases on global health systems. The recently emerging pandemic COVID-19 was a testimony to the huge importance such diagnostic kits can have in combating the diseases such as in preventing community spread.
Over the period of analysis, the global gene delivery technologies market is projected to develop at a healthy growth pace. The emergence of cell and gene therapy has played a significant role in restructuring the entire pharmaceutical landscape.
The T-cell therapy market is anticipated to rise at a stellar growth rate for the forecast period between 2020 and 2030. The shift in medical practices from small molecule and protein-based therapies to adoptive therapies that has attracted strategic investments by both public and private agencies is creating opportunities in the T-cell therapy.
The preparative and process chromatography market is anticipated to display phenomenal growth rate over the forecast period from 2020 to 2030. Large-scale integration of liquid chromatographic methods in downstream processing, high demand for preparative methods, and technological advancements are accentuating growth in the preparative and process chromatography market.
Biological products or biologics refer to medicines manufactured using living organisms. For the manufacturing of these products, highly complex processes are performed under strict observations and controlled conditions. Therapeutic proteins, gene and cell therapies, blood products, monoclonal antibodies, growth factors, cytokines, insulin, fusion proteins, vaccines, and interferon are some of the products included in biologics.
The growth of the global immunofluorescence assay market is ascribed to the rising prevalence of various chronic illnesses. In addition, increased spending on healthcare and research and development activities are likely to work in favor of the global immunofluorescence assay market.
Major advancements in medical science and technology, coupled with the increasing adoption of personalized medicine initiatives are likely to aid in expansion of the global DNA & RNA banking services market during the forecast period set between 2020 and 2030.
The growing prevalence of coronary artery diseases stands as a key factor aiding in expansion of the global antisense and RNAi therapeutics market and is likely to continue so during the forecast period set between 2020 and 2030.
There has been augmented focus on personalized medicines and drug discovery utilizing in vitro methods. In addition, the demand for humanized animal models is also witnessing a rise, which is likely to open plethora of opportunities for the players in the global genetic toxicology testing market in the near future. However, reluctance of regulatory authorities to go for alternative methods for efficacy and safety, shortage of in vitro models, and failure to demonstrate the intricacies of in vivo conditions are expected to restrain market growth.
Increased number of research activities in all worldwide locations is projected to boost the expansion of the global polyclonal antibody market throughout the forecast period 2020–2030. Polyclonal antibodies refer to a heterogeneous combination of antibodies resulting from the immune response of manifold B-cells.
Ophthalmoscopes or also called direct ophthalmoscopes are hand-held optical instrument used to inspect not just fundus or back of the eye. These are used to assess the health of the eyegrounds comprising retina, optic nerve, vasculature and vitreous humor, and subjacent choroid.
Growth in the global infrared and terahertz spectroscopy market can be influenced by technological advancements and strict regulations prevalent in the pharmaceutical sector. In addition to that, augmented government spending in infrared technologies and rising concerns about food safety is expected to work in favor of the market over the assessment timeline, from 2020 to 2030.
Deficiency of Vitamin D is a common issue faced by many across the globe. It is more common amongst the older adults. Vitamin D plays a vital role in the calcification and development of bones, which is why many people are looking for easy options to test their level of Vitamin D.
Live cell imaging has attracted the interest of biomedical researchers. The expanding application of cell imagers in life sciences industries is a key evolutionary trend in the cell imagers market.
The growth of the global cell separation market is estimated to be driven by the growing interest of scientists and biotechnology companies in stem cell research.
COVID-19 refers to a viral infection occurred due to a corona virus named SARS-CoV-2. This virus attacks the respiratory tract of an individual. The COVID-19 virus is communicable disease and can spread due to direct contact with the infected individual or due to indirect contact with surfaces in the immediate environment.
Chronic diseases often lead to catastrophic damage to vital organs. This damage is usually irreversible and leads to lifetime dependency on medicines. Under such severe conditions, transplants remain the component for restoration of healthy life.
The platelet concentration systems market s expected to gain promising growth across the assessment period of 2020-2030. The increasing prevalence of musculoskeletal injuries may serve as a prominent growth booster for the platelet concentration systems market.
Biopsies have remarkably advanced the molecular medicine in general and oncology in particular. Technological strides in the devices used for biopsies have considerably improved the molecular characterization of cancers.
The demand within the global spatial genomics and transcriptomics market is expanding at a stellar pace in the years to follow. Advancements in molecular biology have paved the way for revenue inflow into the global spatial genomics and transcriptomics market.
The single-use bioprocessing probes and sensors market may harness promising growth across the assessment period of 2019-2029. The increase in the adoption of single-use systems across the bioprocessing industry may help the single-use bioprocessing probes and sensors market to obtain immense growth prospects.
Rapid and accurate treatment and diagnosis of various clinical disorders are vital for best clinical outcome. Enzymes find extensive use in the diagnosis of an extensive range of illnesses, thanks to its excellent biocatalytic properties.
Semi-quantitative antibody testing has been granted approvals and licenses to access the diagnosis of lethal viruses such as SARS-COV2, by evaluating the level of IgG that binds the spike protein of the coronavirus. The COVID-19 has boosted the semi-quantitative antibody testing market, fueled by the demand for mas scale testing to curb the infection
Pyrogens are substances that lead to causing fever after administration of an injection. Rise in the body temperature and body ache are some of the prominent reactions that are caused because of injection of these harmful pyrogens in the human body. Pyrogen testing determines the presence of endotoxin substances.
Microbial identification has become an important aspect of the overall healthcare domain. With the growing prevalence of infectious diseases, increasing frequency of global pandemic, and rising food safety concerns the need for rapid and reliable microbial identification has become highly important. In addition to this, the global microbial identification market has benefitted from growing governmental support and funding.
The RNA analysis/transcriptomics market may gain immense growth across the assessment period of 2019-2029 on the back of the escalating advancements across the transcriptomics sector. The phenomenal rise in the investments of both private and non-private entities may bring tremendous growth prospects for the RNA analysis/transcriptomics market during the tenure of 2019-2029.
The global analytical standards market provides increasing public concerns related to optimum food quality and safety, increasing applications of different analytical techniques in proteomics & metabolomics, and better regulatory emphasis on efficient pollution control and monitoring are some of the important factors driving the growth of the analytical standards market.
The cell therapy technologies market is expected to gain immense growth opportunities through the forecast period of 2019-2029 owing to the rising influence of cell therapies across the life sciences sector. The overwhelming need for novel and enhanced therapies for a variety of diseases and disorders may bring extensive growth prospects for the cell therapy technologies market during the forecast period.
Tissue engineering refers to an interdisciplinary sphere that uses combination of life sciences and engineering. The main motive of this technology is to develop biological substitutes that can help in restoring, upholding, or advancing the function of tissues. Increase in instances of various chronic health issues is projected to boost demand opportunities in the global tissue engineering market from 2019 to 2029.
Proteins are biocatalysts and explicit for quickening different sorts of synthetic responses without going through self-changes. The compounds are right now utilized in different applications in DNA control, examination, and biotechnology, and so forth.
The demand within the global immunoprotein diagnostic market is slated to reach unprecedented heights in the years to follow. The relevance of studying and analysing various types of proteins in the human body has given a thrust to the growth of the global immunoprotein diagnostic market.
The growth of the global cervical dysplasia market can be attributed to advancements in female healthcare. Characterised by abnormal cell growth in women, cervical dysplasia is grouped as a severe condition as it can lead to cancer if left untreated.
Synthetic biology market has evolved on the back of surging industry interest worldwide on the profound capabilities it is said to possess, mainly by virtue of redesigning biological components and systems. The spectrum of transformative effects of synthetic biology is expanding at a breakneck pace, but arguably the strides may be mixed with the hype. Most prominently, new approaches in the synthetic biology market have carved a new hope for production of small molecules.
Bone regeneration refers to a well-orchestrated and complicated physiological process of bone formation. This process is observed at the time of normal healing of fracture and is continuously remodeled throughout adulthood. The result of such an immensely complicated process of regeneration is the restoration of function and form of bones.
The drive for molecular biology enzymes, kits and reagents, stems from steady strides being made in life sciences industry. Purified functional protein reagents is one of the cornerstones of emerging molecular biology techniques, shaping the demand trends of the consumables.
Since the last decade, technologies and techniques for rapid sequencing of human genomes have made incredible strides. The advent of high-throughput sequencing technologies—sensors and tools—has opened up a vast area of research in human biology, human diseases, and treatment responses in animals.
In simple words, apoptosis assays refers to programmed cell deaths, which are able to regulate genetically cell ablation over the period of normal development. It is utilized for the purpose of elimination of unhealthy, unnecessary, and old cells sans any release of harmful materials into the adjoining areas.
Growing worldwide population living with numerous disease conditions is projected to stimulate fabulous demand opportunities in the US therapeutic plasma exchange market during 2019–2029. Upcoming research report from TMRR highlights that the market for US therapeutic plasma exchange will expand at rapid pace on the back of ongoing technological advancements in the healthcare sector.
In recent months, there is a striking increase in the spread of COVID-19 infection in all worldwide locations. As a result, there is remarkable increase in the number of tests performed for the detection of COVID-19. Vendors operating in the COVID-19 detection kits are experiencing burgeoning demand avenues from all across the world.
Bacterial and viral collection is done in healthcare settings to diagnose the kind of disease an individual has. It is essential that specimen collection be done in a sterile manner to not pick up environmental contaminants.
The growth of the global d-dimer testing market is ascribed to its high demand across the globe. Shortage of radiological interventions, cost effectiveness, and high accuracy is expected to bolster demand for d-dimer tests over the timeframe of analysis, from 2019 to 2029.
Cathepsin B is an important mediator of inflammation and programmed cell death in individual cells. It has a role in inducing cell dissolution and recycling of cellular organelles. This organic molecule has been implicated in various cancers and other chronic conditions like Alzheimer's disease and seizures, being primarily involved in the diminution of memory with progress of disease.
Lentiviral vectors find utilization as a medium to make a delivery of foreign genetic material into a separate cell. Making use of a type of retrovirus, a lentivirus, these vectors are produced. Lentivirus comes with long period of incubation and is able to cause infection in both non-dividing as well as dividing cells.
The global industrial microbiology market is growing, thanks to the rising preference for industrial automation across the globe. This growing emphasis on industrial safety and industrial food and hygiene is likely to work in favor of the market over the tenure of assessment, from 2019 to 2029.
Spheroids and organoids are 3D models or cultures that can recapitulate organ features ex vivo, thereby opening new paths to diagnostic and therapeutic assessment. Their use in advancing research in personalized medicine and drug discovery has added momentum to the expansion of the organoids and spheroids market. In recent years, they have appeared as promising tools for normal and diseased tissue modelling. More bewilderingly, the potential of organoids and spheroids in recapitulating the heterogeneity and pathophysiology of human cancers is astounding. The drive for next-generation revenues in the spheroids and organoids market stems from the evolving paradigm of preclinical cancer research.
The outsourcing of biologics has seen a tremendous rise over the years prominently due to its benefits such as decreased investment in drug development and large-scale provision of manufacturing capabilities. The SARS-CoV-2 pandemic has led to increased demand in the biopharmaceuticals contract manufacturing market due to the race in finding a curable vaccine for COVID-19. This aspect may bring good growth opportunities for the biopharmaceuticals contract manufacturing market.
RNA-based gene silencing has been heralded a novel means for drug target identification and validation. These have squarely addressed the limitations pertaining to RNA-based vaccines for viral infections and various cancers, particularly inefficient delivery issues and safety. More specifically, RNA interference (RNAi) plays a key role in gene silencing, hence in some promising target gene identification. These developments form the key pivot in the evolution and recent strides in the RNA based therapeutics and vaccines market. RNA based therapeutics form attractive part of applying RNA virus vectors and non-viral delivery for vaccine development.
RNA-based biopharmaceuticals is a comparatively new class of treatment and it comprises vaccines and therapeutics. These biopharmaceuticals are prophylactic medicines that are used in the treatment of various rare and chronic diseases, which includes certain cardiovascular conditions, tuberculosis, diabetes, and cancer. The main objective of RNA therapeutics is to invent a cure for rare diseases and various unmet clinical conditions. This field is research-based and advancement made in the field of technology is likely to expand the global RNA-based therapeutics and vaccines market over the tenure of assessment.
The measles, mumps, and rubella vaccines market is observing significant growth due to high incidence of pneumococcal infections. Measles, mumps, and rubella are common communicable diseases. Measles, mumps, and rubella are airborne viral diseases that are spread by sneezing and coughing of an infected individual, which can sometimes lead to serious complications or can be fatal.
The DNA polymerases refer to those enzymes that generate DNA molecules through assembling of nucleotides. Nucleotides are the building blocks of DNA. These enzymes are considered crucial for the replication of DNA and generally work in pairs so as to make two similar DNA strands from one single DNA molecule. Over the course of the process, DNA polymerase is able to “read” the existing DNA strands to generate two new strands matching with the existing ones. The global DNA polymerase market is expected to observe growth in the rising number of research and development projects.
Peptide synthesis refers to the process of creating short sequences of polypeptides through addition of one amino acid at a time. The peptide synthesis process is beneficial for the purpose of generating specific sequences representing epitopes of specific protein domains that might or might not be altered by moieties like phosphate groups. Peptide molecules have gathered considerable traction in the nutrition and healthcare industry, which is likely to foster growth of the global peptide synthesis market in the forthcoming years.
The drive for application in life sciences tools between life science researcher stems from the need for bioinformatics for unearthing a diverse array of scientific data. The research fraternity and industry alike leverage life science tools for gaining insights into various elements: DNA and RNA sequences, protein structures, biological pathways in drug making, and biological signals useful for disease prognosis. The major application areas in life sciences market include genetics and cell biology. Life sciences tools hold potential in biological data acquisition, data mining, and analysis. The life sciences industry affinity to leverage the potential of computation tools in synthetic and systems biology has led to the evolution of the life sciences tools market.
The global viral vector and plasmid DNA testing services market is estimated to be influenced by the increased innovation and spending in research and development activities relating to the field. Viral vectors are those tools that are popular amongst the molecular biologists and they make wide use of these tools to deliver genetic materials into cells. This same procedure can be conducted in cell culture (in vitro) or inside a living organism (in vivo). Viruses have developed into specialized molecular mechanisms in a bid to carry their genomes inside the cells that they infect. On the other hand, plasmids are small DNA molecules, which are separated physically from the chromosomal DNA and then they are able to replicate on their own.
The growth of the global sarcoma biopsy market relies on advancements in cancer therapies. The rising incidence of leukaemia has created a wide array of opportunities for growth across the sarcoma biopsy market. Several types of cancers have lately been discovered in patients of all age groups. The development of cancerous cells in the human body can cause excruciating pain and discomfort for patients. Moreover, the nature of cancer cells to multiply also cause severe medical problems and complications. The medical industry has set on a quest to develop effective antibodies and antigens that can destroy cancer cells inside the human body. In this regard, it is safe to state that the global sarcoma biopsy market would grow at a stellar pace.
Methicillin Resistant Staphylococcus aureus (MRSA) is the most prevalent multi-drug resistant bacteria and a growing threat to health. The US Centers for Disease Control and Prevention department projects that nearly 1 in 50 people in the U.S. carried MRSA in their bodies in August 2019. Furthermore, these people are nearly four times more susceptible to infection. MRSA is commonly found in hospitals and healthcare facilities and it can cause severe health problems such as pneumonia, bloodstream infections, sepsis, and even death.
A cell bank refers to a facility that helps in the storage of cells of certain genome for future use in medicinal needs or in some product. Cell banks often have large amount of base cell material that can be used in a number of projects. Cell banks are utilized for the generation of detailed characteristics of cell lines and it also assists in the mitigation of cross contamination of the same. Use of cell banks also diminishes the cost of processes of cell culture, thereby offering an economic alternative to continuous keeping of cells in culture. The growth of the global GMP cell banking services market is likely to be driven by the growing popularity of the procedure and emergence of rare diseases across the globe.
The demand within the global DNA/gene microarray market is expected to rise alongside advancements in genetic studies. The study of genes follows from the need for understanding the nature, cause, and effects of various genetic disorders. There has been an increase in the use of next-generation genetic testing and DNA sequencing across the domain of medical research and diagnosis. Medical scientists focus on the study of genetic patterns and DNAs in order to get to the root of several disorders and diseases.
Duplex Sequencing is a commonly used technique to improve DNA sequencing accuracy. Duplex Sequencing was developed to detect rare nucleotide polymorphism. The test is used in very rare mutation in early-stage cancer detection. It is anticipated that rise in the number of cancer cases will drive the duplex sequencing market. Moreover, application of duplex sequencing in DNA liquid biopsies for the diagnostic procedure, aimed at identifying gene mutation and prevent tumor cancer is also going to fuel the growth of the market.
Recombinase Polymerase Amplification is a new isothermal method to amplify the DNA as well as RNA. Recombinase polymerase amplification is simple isothermal reaction technique having fast reaction time and also known for its accuracy. Application of recombinase polymerase amplification in cancer research and clinical diagnostic procedure is aimed at identifying the genetic defect and prevent the genetic disorder. Such diagnosis applications is going to fuel the growth of recombinase polymerase amplification market.
Multiple displacement amplification is a commonly used technique for amplification of DNA that can amplify DNA from a sample having a trace amount of DNA. Multiple displacement amplification is used in forensic testing where the amount of DNA sample is limited like saliva, blood, hair, skin, and semen sample. It is anticipated that rise in number of forensic cases will drive the multiple displacement amplification market. Application of multiple displacement amplification in Preimplantation genetic diagnosis procedure that is aimed at identifying genetic defect and prevent the genetic disorder is also going to fuel the growth of the market.
Applications of microbiome in medical sciences have created a plethora of opportunities for growth and advancement within the global market. There is no single area of medical research that exclusively uses microbiomes for the study of recovery and health patterns in the body. On the contrary, microbiomes can be considered as one of the smallest components of the human tissues that facilitate development and recovery of tissues.
The global RNAi Technology Market is on a trajectory that will take the market worth up to an impressive figure by the end of the forecast period of 2018 to 2028, thanks to a steady growth rate, compounded annually, accelerating the growth momentum.
The brain mapping research along with the investigation projects, as well as the technological developments in tools and algorithms that are being implemented in neuroscience space are among the primary factors contributing to the progress of the global neuroscience market. The neuroscience-based initiatives by government bodies are further driving product adoption in the global market.
Cryotherapy refers to a medical therapy that finds its use in the application of low temperature to a damaged or an injured part of a body. Cryotherapy is extensively used for the purpose of treatment of post-operative swelling, swelling, sprains, soft tissue damage, and muscle pains. This new form of treatment is regarded as one of the most promising procedure for cancer treatment, which is likely to drive the global cryotherapy market.
The global CAR-T cell therapy market is set to chart stellar growth owing to an impressive CAGR (Compound Annual Growth Rate) between 2018 and 2028. Multiple factors driving growth in the market, and thus contributing to generation of a plethora of growth opportunities, include increase in incidence of cancer and rising investment in the field of immune oncology.
The global Recombinant Human Endostatin market report is an-depth study of drivers, trends, and economic forecast. The market report will highlight on the ongoing potential of the collagen which promises a breakthrough in the treatment of cancer. The current research is focus on disrupting the growth of blood vessels that nourish blood tumor cells.
The nerve biologic products market report is an-depth study of various trends, growth factors, and economic forecast. The report is expected to highlight key new opportunities in the market with a detailed forecast of the future. Additionally, nerve conduit, nerve graft, and nerve wraps, and nerve capping devices will be studied in detail with segmentation for each.
Advancements in medical research has played an integral role in the growth of the global ubiquitin enzymes market. The use of granular techniques to study protein structures found in humans has aided market growth. Furthermore, ubiquitin enzymes are widely used for studying localization of proteins within the human body. The medical fraternity has become increasingly concerned about the study of cell multiplication and division.
Gram Positive Bacterium, Clostridium Difficile, is cause for concern, particularly because infections related to this are a cause for hospital acquired infectious diarrhoea. And, the fact is widely recognized. And, this requires developing a prevention vaccine for the disease, to counter the anaerobic toxin which transfers through fecal oral route.
Many patients who undergo dialysis often do not have a suitable vein from which impure blood can be removed. This is due to a blocked vein or narrow vein in the body that prevents doctors from carrying out hemodialysis. As a result, physicians insert a graft to facilitate removal of impure blood from the patient’s body.
Advances in recombinant technology have enabled researchers to utilize the thrombolytic activity of tissue plasminogen activator (tPA) in synthetic products. The tissue plasminogen activator market has thus witnessed a growing array of recombinant tissue plasminogen activators with useful pharmacokinetic and pharmacodynamic properties. Key products comprise alteplase, reteplase, and tenecteplase.
Non-insulin treatments are generally utilized in type 2 diabetes patients, where body either doesn't deliver enough insulin or can't successfully utilize the insulin it produces. Non-insulin-based drug works with various system of activity to lessen blood glucose level and keep up it for ideal glycemic control.
Monoclonal antibodies assume a significant job in indicative prescription during tests to decide the centralization of explicit proteins in blood or pee. For example, high blood level of a prostate-explicit antigen, estimated by its connection with a monoclonal counter acting agent, gives an early cautioning to prostate malignancy. Antibodies to target biomarkers are generally utilized for identifying cancer-causing embryonic antigen.
Lyophilization has been popularly employed by the pharmaceuticals industry in parenteral product development. The process has the potential to improve the shelf-life, increase the efficacy of formulations, especially complex injectables, and to make them easier to store and transport. Biopharmaceutical companies adopt lyophilization services for manufacturing sterile lyophilized bulk APIs and drug products.
Advancements in science and technology has aided in improving healthcare outcomes. With better diagnostic and treatment techniques at the behest, doctors are able to prevent patients from suffering and improve treatment process, time, and reduce expenditure. While developing chemical formulations that treat a condition has been a traditional approach for most pharmaceutical companies, the provision to find biological methods of treatment that are less complicated and equally effective has been trending in the last few years.
Autologous matric-induced chondrogenesis is a new type of treatment method for repairing articular cartilage damage. It is a single step procedure that makes use of microfracturing method. This step is then followed by applying a layer of bilayer collagen I/II membrane. This membrane is applied with the help of partially autologous fibrin glue.
Plasma refers to the liquid portion of one’s blood, in which vitamins, white and red blood cells, and salts are found. Most of the content of plasma comprises water. The plasma turns yellow in color, once red blood cells are removed from it. The global platelet rich plasma market is driven by the growing incidences of bone-related disorders and arthritis.
It is just handful of companies that are into the distribution and manufacturing of most of the insulin used in the developed countries. A number of new market players have developed its insulin making capacities and such a development is based on the methods of modern biotechnology.
The 3D cell culture market is seeing a steady development because of the elements, as tremendous ventures by life science organizations for R&D, advancement of robotized enormous scale cell culture frameworks, and rising requirement for organ replacement. Absence of experienced and gifted experts and spending confinement for little and medium-sized labs are factors obliging the development of the 3D cell culture market.
The global animal genetics market is likely to rise at a healthy growth rate over the assessment timeframe. Augmented consumption of protein extracted from animals is prophesized to favor the growth of the global animal genetics market in the forthcoming years. In addition, increasing populations generates massive demand for animal-based protein, which further benefits the market.
The demand within the global stem cell banking market is growing on account of advancements in the field of regenerative medicine. The medical fraternity has become extremely focused towards the development of artificial tissues that can infuse with the human body. Furthermore, medical analysis and testing has gathered momentum across biological laboratories and research institutes.
Natural killer cells are generally big granular lymphocytes. These cells react quickly to any pathological problem. In addition to this, these natural killer cells are responsible for the production of immunoregulatory cytokines. Also, these natural killer cells act as a key component of the overall immune system of the humans. The role of these natural killer cells is the produce a quick immune response against different types of infections and malignancies.
Next generation sequencing is also known as non-Sanger based high throughput DNA sequencing technology. This term is particularly used for defining advanced and modern sequencing technologies such as Roche 454 Sequencing, Illumina (Solexa) Sequencing, Proton/PGM sequencing, and SOLiD sequencing among others. Billions of DNA strands are chained in parallel that provide considerable more throughput.
Particle therapy or radiation therapy involves use of X-rays and high energy rays that destroy the cancerous cells in the tumor or target area. However, it also destroys normal and healthy cells near the target cell area. It can lead to several side effects on the body such as dry mouth and nausea. For tackling such issues, researchers have introduced absorbable tissue spacers that counter these side-effects.
The success of a biochemical research depends on the level of integrity maintained by scientists and lab experts. The need for clinical trials and testing stems out of the rising incidence of chronic disorders such as cancer and cardiac dysfunction. Hence, the global clinical reference laboratory services market is set to expand at a stellar pace in the years to follow. The need to delve into the details of genetic disorders, coupled with advancements in cytogenetics, has played a key role in market growth.
Organism’s immune system creates a sub-type of protein called immune repertoire. Immune repertoire sequencing is highly applicable in infectious disease research, biomarker discovery, cancer immunotherapy, and asthma and allergy research. Immune repertoire sequencing also assists scientist and researchers in understanding and examining adaptive immune-mediated diseases.
Industrial microbiology encompasses the use of microorganisms and their metabolites for a wide variety of industrial products. Products derived from microbial products include a variety of beverages, food additives, healthcare products, and biofuels.
Single-cell omics advances fill in as incredible assets to dismember cellular heterogeneity exhaustively and to recognize unmistakable phenotypic cell types, even inside a 'homogeneous' functional bacteria.
The global research antibodies market is predicted to be a progressive one over the forecast period. The exceptional physiological properties of antibodies make them sought-after for cell research. Antibodies have the ability to bind to specific molecules, which allows molecules of interest to be isolated for cell research.
Blood plasma and its derivatives form a significant source of medicines. Plasma primarily contains immunoglobulin, clotting factor, and albumin and acts as a vital transporting medium for cells and nutrients in the human body.
Polyclonal antibodies (or immunoglobulins) are potentially powerful tools in a wide range of biomedical and biochemical research, world over. Mammalian sources of these proteins have widespread in a variety of therapeutic applications pertaining to assessment, detection, and purification of specific proteins.
The elimination and inactivation of viruses continues to remain an important field of research in the field of bioprocess safety. With increased research activities in the field of viral clearance in the past few years, viral clearance methodologies have become more specific to individual situations and industrial applications. Along with this, the global viral clearance market has also expanded in its purview.
The demand within the global market for desalting and buffer exchange has been rising on account of the rising popularity of chromatography experiments in the chemical industry. The basis of desalting and buffer exchange is to separate macromolecules from relatively smaller molecules. A secondary component of this process is the replacement of the buffer system with another system that can help in downstream applications.
The global market for personalized retail and wellness has witnessed a plausible rise in its valuation as well as its global outreach in the past few years. From a vast rise in the number of products across categories such as functional food and nutraceuticals to the vast advancements in the field of metabolic profiling, the market has achieved great strides and continues to expand at an impressive pace.
Metagenomics has emerged as a new paradigm in microbiology in the genomic analysis of genetic material recovered from microbial communities. The approach has recently generated vast interest among microbiologists across the world in supporting the underlying research techniques for studying the vast range of microbes present in environment.
The technique offers a mathematical or quantifiable basis for the proper assessment of the effects and the time course of drugs in the body, allowing the quantification of the four key processes associated with drug exposure on the body: absorption, distribution, metabolism, and excretion.
The report details an exhaustive account of the global biopharmaceuticals manufacturing consumables testing market along with numerous associated factors. Some of these factors that are included in the report are drivers, restraints, competitive analysis, latest trends and opportunities, geographical outlook, and many other aspects.
The global market for human liver models is expected to grow at healthy growth rate in the next few years. Technological advancements and innovations in this field are further estimated to accelerate the growth of the market in the coming years.
Substantial and complex atoms delivered from qualities of living life forms by utilizing advanced DNA innovations are all in all recognized as biologics. Biologics are effectively combined, while being developed from new pharmaceuticals and additionally replaced with existing medications.
The global rare neurological disease treatment market is projected to get a shot in the arm with increasing initiatives taken to improve patient care and rising focus on new drug formulations. New potential areas of research and development are keenly investigated into by pharmaceutical firms as a result of the decline in the number of blockbuster drugs.
The global fill-finish manufacturing market is forecast to expand at a decent CAGR between 2017 and 2025. Players could benefit from the rise in fill-finish outsourcing witnessed in the recent years. Moreover, there are several technological developments that the market has testified of on the part of fill-finish products.
The world market for efficacy testing is expected to grow at a robust CAGR and is anticipated to attain a significant market valuation by the end of the period of forecast.
The global biologic therapeutics market is predicted to benefit from the rising applications of biological products. Biological products could be made of sugars, nucleic acids, proteins, or complex combinations of these substances, or may be living components such as cells and tissues.
Organ-on-chip is multichannel 3D micro-fluidic cell culture gadget, which prompts mechanisms, activities, and physiological reflexes of human organs. This chip builds up a thin channel for the air and blood flow in organs including gut, lung, heart, liver, and so on.
The global epigenetics market is expected to grow at a fast paced CAGR in the next few years, owing to factors such as extensive use in the research of developmental and disease process, and growing importance of Life Science. Increasing incidences of cancer and other life threatening diseases will also drive the growth of the global epigenetics market.
Also known as genome editing with engineered nucleases (GEEN), genome editing is a method of altering DNA within a cell in a safe manner. The technique is also used for removing, adding, or modifying DNA in the genome.
Based on products and services, the global high-resolution melting analysis market can be segmented into software and services, consumables and reagents, and instruments. In terms of application, it can be segmented into epigenetics, pathogen identification, species identification, mutation scanning, and SNP genotyping.
In biomanufacturing, high throughout process development tools and technology platforms could be engaged for a simpler and faster development of downstream chromatography processes. High throughput process development is expected to address the concern about reducing development time and designing scalable and robust processes by increasing process knowledge.
High-content screening (HCS) refers to a technique used in biological research and drug discovery to discover substances such as peptides, small molecules, or RNAi that change the phenotype of a cell as desired. Phenotypic changes may include increase or decrease in the production of cellular components such as protein and/or alterations in the visual appearance of the cell.
The growth of microbiology testing market is primarily driven by the recent technological advancements that have not only made the tests faster, they are more accurate now as well as affordable for a larger consumer base. In the medical field, microbiology has always been a branch of enthusiasm that has promised a lot as far as prevention, diagnosis, and treatment of infectious diseases is concerned.
Cell culture protein surface coatings help in improving cell attachment, growth, and differentiation. They facilitate consistent performance in various cell-based assays and in-vitro culture by improving cell adhesion. A variety of adhesion proteins and other biological materials derived from various sources are being used to enhance performance in cell culture, especially in cell lines that are hard to attach, such as transfected cells.
Filters are applied in many stages during the production of small molecule drugs, also referred to as active pharmaceutical ingredients (API). They remove or lessen the particles and bacteria in process components. The filters prevent process solutions from getting contaminated when stored in tanks.
Sterility testing finds application for use on raw materials, cell banks, and final drug offerings. However, it is also used for testing various articles, preparations, and substances which are needed to be made sterile as per the laws penned down by the European Pharmacopoeia (EP) and United States Pharmacopoeia (USP).
Downstream processing involves the purification and recovery of biosynthetic products especially pharmaceuticals from natural sources. This includes animal or plant tissue including salvageable components that can be recycled and proper treatment and disposal of waste.
Cannabis testing includes a number of drug test methodologies pertaining to the use of cannabis in sports, medicine, and law. Unlike alcohol, which can be tested using a breathalyser, cannabis testing requires hair analysis, saliva tests, and urinalysis, and is a time consuming process.
Metabolomics refer to the study of the metabolites that exist within an organism, tissue, or a cell. Processes such as interpretation, quantification, identification, and profiling are used for the understanding the entire set of metabolites in a given biological system.
The trillions of microorganisms living in and on the human body are collectively referred to as human microbiome. These microorganisms include bacteria, protozoa, and fungi. They exhibit a mutualistic relationship and have, therefore, evolved with their human hosts.
The global mice model market has been growing at a healthy rate and is likely to continue at the same pace in the near future. A significant rise in the biomedical research in the healthcare and pharmaceutical sector is anticipated to accelerate the growth of the global market in the forecast period.
A biomarker is considered as a biological gene or molecule which is being used extensively across the globe in order to evaluate accurate pharmacologic responses, biological procedures, and pathogenic procedures. In addition, biomarkers are used to check body’s response to a specific treatment for a condition or disease.
Also called regenerative medicine, stem cell therapy encourages the reparative response of damaged, diseased, or dysfunctional tissue via the use of stem cells and their derivatives. Replacing the practice of organ transplantations, stem cell therapies have eliminated the dependence on availability of donors. Bone marrow transplant is perhaps the most commonly employed stem cell therapy.
As the frequency of outbreaks of influenza increases globally, the global market for influenza diagnostics is likely to soar. Commonly known as flu, influenza is an illness of the respiratory system caused by viruses. According to the World Health Organization (WHO), influenza is responsible for 250,000 to 500,000 deaths worldwide, making it the second leading disease resulting in mortality, after acquired immune deficiency syndrome (AIDS).
Clinical laboratory services are a crucial part of the medical and healthcare industry. All sorts of diagnostic tests ranging from genetic analysis to blood tests are accomplished in these clinical laboratories in order to diagnose various diseases. Clinical laboratories provide services and information which help in maximizing the required deliveries in the healthcare system such as test results and diagnostics.
Biotechnology is the employment of organisms and living systems in order to develop products or a technological application that further uses derivatives, living organisms, and biological systems thereof, in order to create or modify processes or products for specific use. Relying on the applications and tools, it at times overlays with related fields such as molecular engineering, biomanufacturing, biomedical engineering, and bioengineering.
Biopreservation involves maintaining the functionality and integrity of cells, tissues, and organs outside their natural environment for an extended period of storage at different temperatures. For instance, vaccines save 3 million lives every year in the U.S, however, vaccines worth US$ 20 million are wasted each year due to inadequate storage and improper refrigeration.
In the past few years research and development of CRISPR or clustered regularly interspaced short palindromic repeats has allowed molecular biologists to designs solutions for repairing cells by genome editing. This method allows a change to a specific genome by the introduction of a new function or by correction of a mutation. The exceptional fidelity, simplicity of construction, and low cost has triggered a monumental demand for the several solutions offered by the global CRISPR and CRISPR-associated (Cas) genes market.
The international botulinum toxin (BNT) market is gigantically advantaged by the soaring number of applications for different purposes. A recent study has revealed that BNT can be used for benefitting patients with shoulder disorders such as those who undergo rotator cuff surgery. BNT in the form of onabotulinum toxin A (OnabotA) is licensed in several countries such as Korea to help with neurogenic detrusor overactivity (NDO) induced urinary incontinence attributable to multiple sclerosis or spinal cord injury.
The report on clinical laboratory tests market presents a detailed analysis of the key trends, opportunities, challenges, and growth drivers of the market, along with authentic charts and figures. The projected, present, and past leading segments of the global clinical laboratory tests market are examined in the report. The report aims at providing insights into the supply and demand dynamics, competitive landscape, market attractiveness, and key opportunities presented by the regional markets.
The global market for cell sorting has witnessed significant traction in the past few years. Factors such as increasing and easy availability of advanced cell sorters in the global market, rapid technological advancements in product features, and increasing investment and funding are among the key factors to have driven the market in recent times.
A humanized mouse is referred to as a mouse transmitting functioning human organs, tissues, cells, and genes. Humanized mice are basically employed in medical and biological therapeutics as animal models. Immunodeficient mouse are often act as recipients of tissues or human cells, as they can easily receive heterologous cells because of lack of immunity in the host.
Bioprocess technology forms the backbone of the biotechnology industry. In a bioprocess living cells such as bacteria, enzymes, and chloroplast or their components are used to procure desired products. The process is leveraged to develop industrial products, processes and techniques to fulfill the needs of society.
The global pharmaceutical membrane filtration market is expected to witness strong growth throughout the forecast period. The presence of a strong biologics pipeline and the growth potential in several developing economies are some of the major factors anticipated to fuel the growth of the overall market in the next few years. The research study has highlighted the anticipated growth rate and the shares of each segment in the global pharmaceutical membrane filtration market to offer a clear picture and detailed understanding.
Cellular analysis technology has wide applications in cell identification, target identification and validation, and cell counting. The technology is widely used in analysis of cell interaction, cell proliferation, cell structure, cell viability, and cell signaling/cell transduction. Prominent applications of cellular analysis include its uses in various phases of the drug discovery process, oncology, blood cell analysis, and toxicity testing.
The global market for in situ hybridization is projected to expand at a phenomenal rate, with the cancer diagnosis segment at the forefront. The in situ hybridization market can include application segments such as neuroscience, cancer diagnosis, immunology, cytology, microbiology, pathology, and developmental biology.
The mycoplasma testing market has been estimated to undergo noteworthy growth avenues in the forthcoming years owing to increasing demand for the products that are used in mycoplasma testing. These testing procedures are likely to increase in the upcoming years due to rising investments in R & D activities that are related to the life sciences field.
The U.S. clinical oncology next generation sequencing (NGS) market has been estimated to grow with increasing clinical applications of the next-generation sequencing across precision oncology. Further, the key companies serving in the market are taking efforts to develop novel platforms that are used in genomic assays. The market is estimated to grow at a CAGR of 14.70% in the forthcoming years from 2022 to 2032.
HSV or herpes simplex virus is responsible for triggering herpes infection in humans. The symptoms of these infections are found most particularly around the mouth or genitals. Both HSV-1 as well as HSV-2 are highly contagious infections and are sexually transmitted.
The recent professional survey studies project that the global bacteriophage market will rise at a steady CAGR of 4.2 % over the forecast period of 2022 to 2032. The rising utilization of the phage therapeutics in prevention, as well as treatment of dysentery, urinary tract infections, and antibiotic resistance infections, is anticipated to foster the growth within the global bacteriophage market in the coming years.
The next generation sequencing market has been predicted to expand at a noteworthy pace owing to increasing genome mapping programs. Furthermore, technological advancements across sequencing platforms, increasing healthcare expenditure, and growing use of next generation sequencing are likely to bolster growth opportunities in the market in the years to come.
The sepsis diagnostic market is likely to expand at a noteworthy pace in the forthcoming year because of the increasing burden of sepsis around the world. Along with this, the rising geriatric population across the world is likely to fuel growth avenues in the market in the near future.
The fetal bovine serum market has been projected to expand with a rapid increase in the consumption of media culture across developing countries around the world. In addition to this, the rising number of R& D activities across the world in order to introduce novel biopharmaceuticals has also been estimated to serve as a revenue generator in the market in the coming years.
The revenue generation opportunities in the bioremediation market are attributed to rapid industrial development across the world in recent years. These developments have resulted in increased contamination of different environmental landscapes, for instance, forests & agricultural lands, freshwater systems, and oceans.
The flow cytometry market has been anticipated to grow with the increasing prevalence and incidence of AIDS/HIV and cancer. In addition to this, an increasing number of public-private initiatives in the areas of immune-oncology and immunology research, and the rising adoption of the techniques of flow cytometry in academia and research are also predicted to contribute to the revenue generation opportunities in the flow cytometry market in the coming years.
The tangential flow filtration market has been expected to grow at a noteworthy pace in the near future. These growth opportunities in the industry are owing to the rising demand for tangential flow filtration instead of regular flow filtration. These tangential flow filtrations provide various advantages, for instance, flow rates, and others.
The research report on global syphilis testing market sheds light on various core trends and drivers that are expected to fast track the growth of the industry in coming years.
The global next-generation sequencing data analysis market is expected to witness strong growth during the forecast period between 2021 and 2031.
The growth opportunities in the nerve repair and regeneration market are growing at a noticeable speed due to numerous factors.
The global mutation detection kits in genome editing market is expected to witness moderate growth during the forecast period between 2021 and 2031. The demand for genome editing techniques and mutation kits has increased substantially in various end-use industries, in the last few years.
The global cell lysis and disruption market is expected to witness moderate growth during the forecast period between 2021 and 2031. Cell lysis and disruption refer to a procedure in which the cell membrane is decomposed in a bid to extract proteins or nucleic acid from a cell.
Regulations for the security of life, well-being of plants and animals, human health, and environmental compliance will influence market players for increased focus on import, export, and commercialization of genetically modified organisms (GMOs).
Cell Cycle analysis is a highly demanded method for the evaluation of cells in the diverse phases of cell cycle. The determination of cellular response to a variety of drugs and biological stimulations is one of the trending elements prevailing in the global cell cycle analysis market. Most of the methods used during the analysis of cell cycle are based on florescence assays.
Genetic analyzers are complex equipment that contain instruments and chemical solutions needed to carry out the genetic analysis of a genome sample. Genetic analysis is extensive that involves DNA sequencing studies, DNA microarray studies, cytogenetic studies like karyotyping, DNA amplification and other processes.
Combi-chem or combinational chemistry is an innovative method of synthesizing multiple chemical compounds within a short turnaround time. Combinational chemistry is considered to be a less time-consuming and labor-intensive option to traditional chemistry, where compounds are synthesized one at a time.
Whole exome sequencing involves the sequencing of all protein-coding genes in a genome. Clinically exome account for 82% to 85% of known disease-causing variants and less than 1.5% to 2% of the human genome, which converts whole-exome sequencing into an effective alternative.
Proteins have found application in the therapeutics industry for long and are much sought after in modern medicine too. This has resulted in a growing number of protein-based drugs in market these days. However, there are quite a few pressing problems associated with their use such as swift degradation and excretion from patients, requiring frequent dosing.
The global immunohistochemistry market is poised to make a bold statement with an impressive growth rate on the back of its irreplaceable application in the detection of the expression of different cancer biomarkers, such as PD-L1, NGS, RBM4, and SASH1.
The increasing investment in research and development of novel therapeutics owing to the rising incidence of chronic diseases has led to immense growth in the global stem cell assay market. In the next couple of years, the market is expected to spawn into a multi-billion dollar industry as healthcare sector and governments around the world increase their research spending.
Transfection is one of the key research efforts leading the studies in synthetic genetics. While transfections can result in the formation of abnormal cells and unpredictable morphologies, the process can also be used to study the formation of genetic make-up and to transform cell structures through their deliberate infection.
Displaying (253) Records
The market for bioreactors and fermenters, which primarily are vessels in which an environment can be created for the growth of microorganisms, is gaining traction from the prosperity of the biopharmaceutical industry. Fermenters are used for the initiation and maintenance of some quantity of fungal or bacterial cells in a controlled mode.
There have been several technological advancements with regards to the collection of blood from animals and its processing methodologies around the globe. This has led to an increased use of blood plasma products in human food and pet food, thus making a positive impact on demand for these products.. In this way, the global animal blood plasma products market is experiencing a significant growth, which is further expected to continue in the future.
The global market for hepatitis E diagnostic tests is treading a growth path as the prevalence of hepatitis E, especially in resource-poor regions is on the rise. Hepatitis E which is caused due to hepatitis E virus is a chief cause of mortality and morbidity in the developing world. Lack of proper sanitation and frequent instances of water contamination in these countries are leading causes of infections and diseases such as hepatitis E.
Displaying (3) Records